
Journal of Medicinal Chemistry p. 1371 - 1378 (1989)
Update date:2022-08-04
Topics:
Rosenberg, Saul H.
Woods, Keith W.
Kleinert, Hollis D.
Stein, Herman
Nellans, Hugh N.
et al.
Azidomethyl-substituted 1,2- and 1,3-diols were prepared from Boc-cyclohexylalanal and evaluated as transition state analogue renin inhibitors, leading to the development of a small (MW < 600), nanomolar inhibitor.Remarkable aqueous solubility enhancement followed the incorporation of an N-terminal urea functionality.Evaluation of selected compounds both in vivo and in vitro demonstrated that while transport across the intestine occurred upon id administration, extensive liver extraction resulted in low systemic levels.
View Morewebsite:http://www.sigmaaldrich.com
Contact:800 558-9160
Address:Industriestrasse 25CH-9471 Buchs SGSwitzerland
Suzhou SuKaiLu Chemical Technology Co., Ltd.
Contact:+86-512-62766020
Address:Floor 4, Building 1, Xinyi Pharmaceutical Valley Wisdom Industrial Park, 415 Changyang Street, Suzhou Industrial Park, Jiangsu Province
Contact:+86-13914766747
Address:Floors 21&22, Jin Cheng Tower, No. 216 Middle Longpan Road, Nanjing
Yueyang Hudex Pharmaceuticals Ltd.
Contact:0730-8748800
Address:Wujiang Bridge,Yueyang Economy & Technology Development Zone
Luoyang Aoda chemical Co.,Ltd.
Contact:+86-379-67518785 67516588
Address:MiaoWan industry district,YanShi City,Henan,China
Doi:10.1080/00397919808007027
(1998)Doi:10.1021/ja01878a059
(1939)Doi:10.1021/ja01560a007
(1957)Doi:10.1134/S107042800812004X
(2008)Doi:10.1002/chem.202004533
(2021)Doi:10.1016/j.jfluchem.2009.06.014
(2009)